Cargando…
Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report
BACKGROUND: Tumor lysis syndrome is a rare and potentially fatal complication of oncologic treatments, especially in solid tumors. To the best of our knowledge, tumor lysis syndrome has never been reported after trastuzumab and pertuzumab combination therapy. Knowledge of risk factors and active pre...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911682/ https://www.ncbi.nlm.nih.gov/pubmed/27312594 http://dx.doi.org/10.1186/s13256-016-0969-5 |